Modal Container (Shows only in EE)
Modal ID: #cookie-management-modal
Open Modal
Close Modal

Upcoming Forum on Improving Critical Tools for Preventing Prescription Drug Abuse

On June 2, the Network for Excellence in Health Innovation (NEHI) will bring experts from across the country to Boston to discuss a critical public health challenge—the abuse of prescription medicines.

Anne McDonald Pritchett, PhD
Anne McDonald Pritchett, PhDJune 1, 2015

Upcoming Forum on Improving Critical Tools for Preventing Prescription Drug Abuse

New and innovative immunotherapy medicines developed by America’s biopharmaceutical research companies are transforming how we fight cancer and are providing newfound hope to patients.

Rather than killing cancer cells directly with traditional tools like radiation or chemotherapy, immunotherapy seeks to harness the immune system’s power to eliminate the cancer or slow its growth and ability to spread. Research shows immunotherapy is improving outcomes and survival rates for some patients, including kidney and lung cancer. In fact, the American Association for Cancer Research just released new research showing that for advanced-melanoma patients, survival rates are improving thanks in part to these new treatment options.

Biopharmaceutical researchers are urgently working to gain new insights into the complex interactions between patients’ immune systems and the cancer cells growing in their bodies with the goal of markedly improving outcomes in many more tumor types. With 836 medicines and vaccines in development for cancer, 80 percent of which have the potential to be first-in-class treatments, millions of Americans living with cancer have hope for a brighter future.

Stakeholders throughout the health care ecosystem are in agreement that new immunotherapy medicines are providing tremendous value to cancer patients in need. See what they are saying below:

Featured Posts

Older female patient talking with an African American female doctor

The unintended consequences of government price setting in Medicare Part D
Doctor speaking with patient with child

Voters across all 50 states want state policymakers to focus on health insurance and PBM practices

PhRMA launches new ad in campaign exposing ways middlemen drive up costs

This website uses cookies and other tracking technologies to optimize performance, preferences, usage, and statistics. By clicking “Accept All”, you consent to store on your device the cookies and other tracking technologies that require consent. You can tailor or change your preferences by clicking “Manage My Cookies”. You can check our privacy policy for more information.